some patients tolerate oral formulations excellently while others require injection-based therapy to minimize adverse effects
:max_bytes(150000):strip_icc()/VWH-GettyImages-2153535371-5484f67e39324cc599cbe523b3a16c4d.jpg)
If pancreatitis is suspected, Wegovy should be discontinued and appropriate diagnostic tests performed urgently Gallbladder problems : Rapid weight loss increases risk of gallstone formation, with cholelithiasis reported in approximately 1.6% of Wegovy users Intestinal obstruction/ileus : Cases have been reported in post-marketing surveillance, particularly in patients with pre-existing GI conditions Management strategies recommended by healthcare professionals include: Eating smaller, more frequent meals rather than large portions Avoiding high-fat, spicy, or heavily processed foods Staying well-hydrated, particularly if experiencing diarrhoea or vomiting, to prevent dehydration and potential acute kidney injury Not lying down immediately after eating to minimise reflux Ensuring adequate fibre intake to prevent constipation Taking the medication on the same day each week to maintain steady levels Most GI side effects improve over time as the body adjusts to the medication, typically becoming less troublesome after 4-8 weeks at each dose level

Pseudoephedrine and phenylephrinecommon decongestantscan raise blood pressure and increase heart rate, effects that may be amplified when combined with semaglutide's impact on your cardiovascular system
Studies indicate improvements in inflammatory markers, though again, distinguishing direct anti-inflammatory effects from those secondary to metabolic improvement remains challenging